Ownership history in FEDERATED HERMES, INC. · 13 quarters on record
This page tracks every 13F SEC filing in which FEDERATED HERMES, INC. reported a position in RELAY THERAPEUTICS INC (RLAY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 36,000 | -35,217 | -49.5% | 0.00% | $188K | $5.22 |
| 2025 Q2 | REDUCED | 71,217 | -25,096 | -26.1% | 0.00% | $246K | $3.46 |
| 2025 Q1 | ADDED | 96,313 | +46,213 | +92.2% | 0.00% | $252K | $2.62 |
| 2024 Q4 | ADDED | 50,100 | +42,231 | +536.7% | 0.00% | $206K | $4.12 |
| 2024 Q3 | REDUCED | 7,869 | -304,575 | -97.5% | 0.00% | $56K | $7.08 |
| 2024 Q2 | REDUCED | 312,444 | -24,046 | -7.1% | 0.00% | $2.0M | $6.52 |
| 2024 Q1 | REDUCED | 336,490 | -263,510 | -43.9% | 0.01% | $2.8M | $8.30 |
| 2021 Q4 | UNCHANGED | 600,000 | — | 0% | 0.03% | $18.4M | $30.71 |
| 2021 Q3 | UNCHANGED | 600,000 | — | 0% | 0.04% | $18.9M | $31.53 |
| 2021 Q2 | REDUCED | 600,000 | -218,309 | -26.7% | 0.04% | $22.0M | $36.59 |
As of 2025 Q4 — sorted by position size